Cargando…

Management of atypical polypoid adenomyoma of the uterus: A single center's experience

Atypical polypoid adenomyoma (APA) is a rare uterine lesion, which has a high rate of recurrence and malignant transformation. How to treat this disease is crucial for the prognosis, but there are few reports on it. We retrospectively reviewed the clinical records of all the patients diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Bo, Zhu, Yingjun, Liu, Yixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895309/
https://www.ncbi.nlm.nih.gov/pubmed/29561413
http://dx.doi.org/10.1097/MD.0000000000010135
_version_ 1783313632301416448
author Ma, Bo
Zhu, Yingjun
Liu, Yixin
author_facet Ma, Bo
Zhu, Yingjun
Liu, Yixin
author_sort Ma, Bo
collection PubMed
description Atypical polypoid adenomyoma (APA) is a rare uterine lesion, which has a high rate of recurrence and malignant transformation. How to treat this disease is crucial for the prognosis, but there are few reports on it. We retrospectively reviewed the clinical records of all the patients diagnosed with APA after surgical therapy in our hospital. All the clinical information, pathological results, treatment, and outcome were retrieved from the clinical records. A total of 43 patients were diagnosed with APA. The median age was 56.0 years (range: 17–71 years). Primary treatments included hysteroscopic transcervical resection (TCR) of the lesions in 34 patients (79.1%), hysterectomy and bilateral salping-oophenrectomy in 5 (11.6%), hysterectomy in 1 (2.3%), and primary cytoreductive surgery for ovary cancer in 3. A total of 42 patients were followed up for a mean period of 26.9 months (range 2–57 months). Three of them recurred. One patient underwent hysterectomy after recurrence, and TCR was performed for the other 2. High-dose progestogen was given to the 2 recurrent patients after TCR. Hysterectomy is the primary therapeutic choice for postmenopausal patients with APA. Conservative treatment of APA with TCR is safe and efficient.
format Online
Article
Text
id pubmed-5895309
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-58953092018-04-18 Management of atypical polypoid adenomyoma of the uterus: A single center's experience Ma, Bo Zhu, Yingjun Liu, Yixin Medicine (Baltimore) 5600 Atypical polypoid adenomyoma (APA) is a rare uterine lesion, which has a high rate of recurrence and malignant transformation. How to treat this disease is crucial for the prognosis, but there are few reports on it. We retrospectively reviewed the clinical records of all the patients diagnosed with APA after surgical therapy in our hospital. All the clinical information, pathological results, treatment, and outcome were retrieved from the clinical records. A total of 43 patients were diagnosed with APA. The median age was 56.0 years (range: 17–71 years). Primary treatments included hysteroscopic transcervical resection (TCR) of the lesions in 34 patients (79.1%), hysterectomy and bilateral salping-oophenrectomy in 5 (11.6%), hysterectomy in 1 (2.3%), and primary cytoreductive surgery for ovary cancer in 3. A total of 42 patients were followed up for a mean period of 26.9 months (range 2–57 months). Three of them recurred. One patient underwent hysterectomy after recurrence, and TCR was performed for the other 2. High-dose progestogen was given to the 2 recurrent patients after TCR. Hysterectomy is the primary therapeutic choice for postmenopausal patients with APA. Conservative treatment of APA with TCR is safe and efficient. Wolters Kluwer Health 2018-03-23 /pmc/articles/PMC5895309/ /pubmed/29561413 http://dx.doi.org/10.1097/MD.0000000000010135 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 5600
Ma, Bo
Zhu, Yingjun
Liu, Yixin
Management of atypical polypoid adenomyoma of the uterus: A single center's experience
title Management of atypical polypoid adenomyoma of the uterus: A single center's experience
title_full Management of atypical polypoid adenomyoma of the uterus: A single center's experience
title_fullStr Management of atypical polypoid adenomyoma of the uterus: A single center's experience
title_full_unstemmed Management of atypical polypoid adenomyoma of the uterus: A single center's experience
title_short Management of atypical polypoid adenomyoma of the uterus: A single center's experience
title_sort management of atypical polypoid adenomyoma of the uterus: a single center's experience
topic 5600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895309/
https://www.ncbi.nlm.nih.gov/pubmed/29561413
http://dx.doi.org/10.1097/MD.0000000000010135
work_keys_str_mv AT mabo managementofatypicalpolypoidadenomyomaoftheuterusasinglecentersexperience
AT zhuyingjun managementofatypicalpolypoidadenomyomaoftheuterusasinglecentersexperience
AT liuyixin managementofatypicalpolypoidadenomyomaoftheuterusasinglecentersexperience